| Ribosome |
2.32 |
0.00e+0 |
113/158 (71.52%) |
MRPL9;MRPL3;MRPS2;...
|
| Ribosome biogenesis in eukaryotes |
2.20 |
0.00e+0 |
52/108 (48.15%) |
IMP4;FBL;HEATR1;...
|
| Spliceosome |
2.07 |
0.00e+0 |
101/150 (67.33%) |
HSPA1A;LSM5;SF3B5;...
|
| DNA replication |
2.06 |
0.00e+0 |
34/36 (94.44%) |
PCNA;POLE3;RFC3;...
|
| Valine, leucine and isoleucine degradation |
2.05 |
0.00e+0 |
42/48 (87.5%) |
PCCB;ACAT1;ACAA1;...
|
| Propanoate metabolism |
2.02 |
0.00e+0 |
30/34 (88.24%) |
PCCB;ACAT1;ABAT;...
|
| Protein export |
1.98 |
2.30e-3 |
17/23 (73.91%) |
OXA1L;SRPRB;SEC63;...
|
| Glyoxylate and dicarboxylate metabolism |
1.92 |
4.02e-3 |
23/30 (76.67%) |
PCCB;ACAT1;MDH2;...
|
| Pentose and glucuronate interconversions |
1.91 |
3.58e-3 |
17/34 (50%) |
AKR1B10;UGT2B28;DCXR;...
|
| Mismatch repair |
1.87 |
5.63e-3 |
22/23 (95.65%) |
PCNA;RFC3;MLH1;...
|
| Fatty acid degradation |
1.87 |
5.12e-3 |
40/43 (93.02%) |
ACAT1;ACAA1;ADH1B;...
|
| Arginine biosynthesis |
1.83 |
6.70e-3 |
17/22 (77.27%) |
CPS1;GLUD1;ARG1;...
|
| Folate biosynthesis |
1.82 |
6.81e-3 |
23/26 (88.46%) |
AKR1B10;AKR1C3;ALPL;...
|
| RNA transport |
1.81 |
6.32e-3 |
128/186 (68.82%) |
PRMT5;PABPC4;EIF1AY;...
|
| Porphyrin and chlorophyll metabolism |
1.78 |
9.65e-3 |
23/43 (53.49%) |
UGT2B28;COX15;UGT2B15;...
|
| RNA polymerase |
1.77 |
9.05e-3 |
23/31 (74.19%) |
POLR2D;POLR1D;POLR2L;...
|
| Alanine, aspartate and glutamate metabolism |
1.77 |
8.99e-3 |
27/37 (72.97%) |
CPS1;ABAT;GLUD1;...
|
| Glycine, serine and threonine metabolism |
1.75 |
9.38e-3 |
31/40 (77.5%) |
CBS;GLDC;AMT;...
|
| Cysteine and methionine metabolism |
1.73 |
1.06e-2 |
43/50 (86%) |
SRM;CBS;MDH2;...
|
| Drug metabolism |
1.72 |
1.09e-2 |
78/151 (51.66%) |
UGT2B28;NME4;ALDH3A1;...
|
| Retinol metabolism |
1.67 |
1.72e-2 |
41/68 (60.29%) |
ALDH1A1;UGT2B28;ADH1B;...
|
| beta-Alanine metabolism |
1.66 |
1.83e-2 |
25/30 (83.33%) |
ABAT;ALDH3A1;CNDP2;...
|
| Steroid hormone biosynthesis |
1.64 |
1.99e-2 |
43/61 (70.49%) |
AKR1C3;AKR1C1;UGT2B28;...
|
| Proximal tubule bicarbonate reclamation |
1.61 |
2.48e-2 |
21/23 (91.3%) |
AQP1;PCK1;GLUD1;...
|
| Citrate cycle (TCA cycle) |
1.61 |
2.41e-2 |
30/30 (100%) |
PCK1;IDH2;MDH2;...
|
| Thermogenesis |
1.58 |
3.25e-2 |
173/232 (74.57%) |
CYC1;ATP5MC3;NDUFS1;...
|
| Caffeine metabolism |
1.58 |
3.37e-2 |
5/6 (83.33%) |
CYP1A2;NAT1;NAT2;...
|
| Metabolism of xenobiotics by cytochrome P450 |
1.57 |
3.56e-2 |
49/77 (63.64%) |
AKR1C1;UGT2B28;ALDH3A1;...
|
| One carbon pool by folate |
1.54 |
4.11e-2 |
15/20 (75%) |
MTHFD1;ALDH1L1;AMT;...
|
| Fanconi anemia pathway |
1.54 |
4.21e-2 |
36/54 (66.67%) |
REV3L;CENPX;REV1;...
|
| Gastric acid secretion |
-1.61 |
4.77e-2 |
63/76 (82.89%) |
KCNQ1;ACTB;MYLK;...
|
| Rheumatoid arthritis |
-1.61 |
4.93e-2 |
78/93 (83.87%) |
ATP6V1B2;MMP3;ANGPT1;...
|
| Other types of O-glycan biosynthesis |
-1.62 |
4.92e-2 |
29/47 (61.7%) |
COLGALT2;C1GALT1;POMT1;...
|
| PI3K-Akt signaling pathway |
-1.64 |
4.43e-2 |
317/354 (89.55%) |
FGF1;RPS6KB1;IGF1R;...
|
| Synaptic vesicle cycle |
-1.64 |
4.43e-2 |
63/78 (80.77%) |
SLC6A4;DNM2;ATP6V1B2;...
|
| Small cell lung cancer |
-1.64 |
4.52e-2 |
90/92 (97.83%) |
TRAF1;PIK3CD;CDKN2B;...
|
| Long-term potentiation |
-1.66 |
3.44e-2 |
61/67 (91.04%) |
RAP1A;RPS6KA3;ITPR2;...
|
| Insulin secretion |
-1.67 |
3.54e-2 |
75/86 (87.21%) |
ATP1B3;ATP1A3;CREB3L1;...
|
| Amino sugar and nucleotide sugar metabolism |
-1.67 |
3.66e-2 |
38/48 (79.17%) |
HKDC1;HK1;GALE;...
|
| Central carbon metabolism in cancer |
-1.68 |
3.67e-2 |
67/70 (95.71%) |
PFKL;SLC1A5;G6PD;...
|
| Axon guidance |
-1.68 |
3.86e-2 |
151/182 (82.97%) |
RAC1;SLIT2;BMP7;...
|
| Hypertrophic cardiomyopathy |
-1.72 |
2.38e-2 |
81/90 (90%) |
CACNA1F;CACNA2D1;EDN1;...
|
| Dilated cardiomyopathy |
-1.72 |
2.53e-2 |
86/96 (89.58%) |
TTN;CACNB2;CACNG2;...
|
| Salivary secretion |
-1.74 |
2.40e-2 |
76/93 (81.72%) |
AQP5;ITPR2;MUC5B;...
|
| TGF-beta signaling pathway |
-1.75 |
2.56e-2 |
81/94 (86.17%) |
CDKN2B;FMOD;RPS6KB1;...
|
| HIF-1 signaling pathway |
-1.76 |
2.42e-2 |
105/109 (96.33%) |
ANGPT1;ALDOA;PIK3CD;...
|
| Carbohydrate digestion and absorption |
-1.79 |
1.65e-2 |
37/47 (78.72%) |
LCT;G6PC3;AKT3;...
|
| Protein digestion and absorption |
-1.79 |
1.79e-2 |
78/103 (75.73%) |
ACE2;SLC7A7;COL17A1;...
|
| Phagosome |
-1.80 |
1.64e-2 |
118/152 (77.63%) |
HLA-F;ATP6V1B2;CLEC7A;...
|
| Bacterial invasion of epithelial cells |
-1.81 |
1.13e-2 |
59/77 (76.62%) |
CAV3;RAC1;SHC1;...
|
| Human papillomavirus infection |
-1.82 |
1.13e-2 |
284/331 (85.8%) |
MAPK3;DLG1;ATP6V1A;...
|
| Mucin type O-glycan biosynthesis |
-1.96 |
4.24e-3 |
20/36 (55.56%) |
GALNT1;GALNT10;GALNT6;...
|
| Lysosome |
-1.96 |
4.84e-3 |
115/128 (89.84%) |
AP1G2;CTSF;AP3B1;...
|
| Regulation of actin cytoskeleton |
-1.97 |
5.65e-3 |
185/218 (84.86%) |
ACTB;PIK3CD;MYLK;...
|
| Arrhythmogenic right ventricular cardiomyopathy |
-1.97 |
6.78e-3 |
70/77 (90.91%) |
JUP;CACNA1F;CACNA2D1;...
|
| Proteoglycans in cancer |
-2.01 |
8.47e-3 |
172/205 (83.9%) |
ACTB;PIK3CD;TLR4;...
|
| Focal adhesion |
-2.09 |
3.77e-3 |
180/201 (89.55%) |
ACTB;RAP1A;PIK3CD;...
|
| Steroid biosynthesis |
-2.15 |
5.65e-3 |
19/20 (95%) |
CYP27B1;HSD17B7;SOAT1;...
|
| ECM-receptor interaction |
-2.36 |
0.00e+0 |
80/88 (90.91%) |
GP1BB;ITGA5;LAMB2;...
|
